European Group for Research In Schizophrenia
1 clinical trials · Sponsor
◉ Watch European Group for Research In Schizophrenia
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia (NCT07084831) | European Group for Research In Schizophrenia | 2027-01-01 |
Track European Group for Research In Schizophrenia automatically
Every clearance here is in the API, with alerts when new ones post.